Skip to main content
. 2004 Mar 5;90(Suppl 1):S7–S10. doi: 10.1038/sj.bjc.6601630

Figure 1.

Figure 1

Mean plasma concentrations of fulvestrant following i.v. and i.m. (short-acting or long-acting) administration.